Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study

BACKGROUND: Long-term prophylaxis with subcutaneous C1-inhibitor (C1-INH[SC]; HAEGARDA, CSL Behring) in patients with hereditary angioedema (HAE) due to C1-INH deficiency (C1-INH-HAE) was evaluated in an open-label extension follow-up study to the international, double-blind, placebo-controlled COMP...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Orphanet J Rare Dis
Huvudupphovsmän: Lumry, William R., Zuraw, Bruce, Cicardi, Marco, Craig, Timothy, Anderson, John, Banerji, Aleena, Bernstein, Jonathan A., Caballero, Teresa, Farkas, Henriette, Gower, Richard G., Keith, Paul K., Levy, Donald S., Li, H. Henry, Magerl, Markus, Manning, Michael, Riedl, Marc A., Lawo, John-Philip, Prusty, Subhransu, Machnig, Thomas, Longhurst, Hilary
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2021
Ämnen:
Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7885603/
https://ncbi.nlm.nih.gov/pubmed/33588897
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13023-020-01658-4
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk